Effect of chemotherapy on malaria transmission among Yanomami Amerindians: Simulated consequences of placebo treatment

American Journal of Tropical Medicine and Hygiene

Volumn 60, Issue 5, 1999, Pages 774-780

  Freeman, Jonathan ^a   Laserson, Kayla F ^b   Petralanda, Izaskun ^c   Spielman, Andrew ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Asoc Civ Invest Contr E   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; FANSIDAR; MEFLOQUINE; PLACEBO; PRIMAQUINE; QUININE;

AMERICAN INDIAN; ARTICLE; DISEASE SIMULATION; EPIDEMIC; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALARIA; MALARIA CONTROL; MATHEMATICAL MODEL; MOSQUITO; ORAL DRUG ADMINISTRATION; PARASITE VECTOR; PLASMODIUM FALCIPARUM;

EID: 0032922909     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.60.774     Document Type: Article

References (36)

1. Balda FV, 1975. Quimioterapia en areas con transmision malarica persistente y resistente del Plasmodium falciparum a la cloroquina en Panama. Bol Oficina Sanit Panam 78: 531-541.
2. Garfield RM, Vermund SH, 1983. Changes in malaria incidence after mass drug administration in Nicaragua. Lancet ii: 500.
3. Gilles HM, Warrell DA, eds, 1993. Bruce-Chwatt's Essential Malariology. Third edition. Boston: Edward Arnold.
4. Gomes M, Salazar NP, 1990, Chemotherapy: principles in practice - a case study of the Philippines. Soc Sci Med 30: 789-796.
5. Molineaux L, Gramiccia G, 1980. The Garki Project. Geneva: World Health Organization.
6. Anderson RM, May RM, 1991. Infectious Diseases of Humans: Dynamics and Control. Oxford: Oxford University Press.
7. Laserson KF, Wypij D, Petralanda I, Spielman A, Maguire J, 1999. Differential perpetuation of malaria species among the Amazonian Yanomami Amerindians. Am J Trop Med Hyg 60: 767-773.
8. Earle WC, Perez M, Rio J, Arzola C, 1939. Observations on the course of naturally acquired malaria in Puerto Rico. P R J Public Health Trop Med 14: 391-406.
9. Aron JL, May RM, 1982. The population dynamics of malaria. Anderson RM, ed. Population Dynamics of Infectious Diseases. London: Chapman and Hall, 139-179.
10. Molineaux L, Dietz K, Thomas A, 1978. Further epidemiological evaluation of a malaria model. Bull World Health Organ 56: 565-571.
11. Saul A, 1993. Minimal efficacy requirements for malarial vaccines to significantly lower transmission in epidemic or seasonal malaria. Acta Trop 52: 283-296.
12. Struchiner CJ, Halloran ME, Spielman A, 1989. Modelling malaria vaccines. I: New uses for old ideas. Math Biosci 94: 87-113.
13. Benenson AS, ed, 1995. Control of Communicable Diseases Manual. 16th edition. Washington, DC: American Public Health Association.
14. Covell G, Nicol WD, 1951. Clinical, chemotherapeutic and immunological studies on induced malaria. Br Med Bull 8: 51-55.
15. Charlwood JD, Alecrim WA, 1989. Capture-recapture studies with the South American vector Anopheles darlingi, Root. Ann Trop Med Parasitol 83: 569-576.
16. Klein TA, Lima JB, 1990. Seasonal distribution and biting patterns of Anopheles mosquitoes in Costa Marquez, Rondonia, Brazil. J Am Mosq Control Assoc 6: 700-707.
17. Zimmerman RH, 1992. Ecology of malaria vectors in the Americas and future direction. Mem Inst Oswaldo Cruz 87 (suppl 3): 371-383.
18. Carlson DG, 1984. African Fever. Canton, MA: Watson Publishing International.
19. Litsios S, 1996. The Tomorrow of Malaria. Karori, New Zealand: Pacific Press, 33.
20. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, Marsh V, Newton C, Winstanley P, Warn P. Peshu N, Pasvol G, Snow R, 1995. Indicators of life-threatening malaria in African children. N Engl J Med 332: 1399-1404.
21. Greenberg AE, Lobel HO, 1990. Mortality from Plasmodium falciparum malaria in travelers from the United States, 1959 to 1987. Ann Intern Med 113: 326-327.
22. MacDonald G, 1957. The Epidemiology and Control of Malaria. London: Oxford University Press, 9.
23. Collett D, Lye MS, 1987. Modelling the effect of intervention on the transmission of malaria in east Malaysia. Stat Med 6: 853-861.
24. Whalen CC, Johnson JL, Okwera A, Hom PL, Huebner R, Mugyenyi P. Mugerwa RD, Ellner JJ, 1997. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. N Engl J Med 337: 801-808.
25. Angell M, 1997. The ethics of clinical research in the third world. N Engl J Med 337: 847-849.
26. Lurie P, Wolfe SM, 1997. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. N Engl J Med 337: 853-856.
27. Bloom BR, 1998. The highest attainable standard: ethical issues in AIDS vaccines. Science 279: 186-188.
28. Molineaux L, 1985. The pros and cons of modelling malaria transmission. Trans R Soc Trop Med Hyg 79: 743-747.
29. Najera JA, 1974. A critical review of the field application of a mathematical model of malaria eradication. Bull World Health Organ 50: 449-457.
30. Maynadie M, Peceno C, Noriega P, Yarzabal L, 1989. Susceptibility of Plasmodium falciparum strains to chloroquine and mefloquine in the Amazonas Federal Territory of Venezuela. Trans R Soc Trop Med Hyg 83: 586-588.
31. Petralanda I, 1995. Quality of antimalarial drugs and resistance to Plasmodium vivax in Amazonian region. Lancet 345: 1433.
32. Fuentes M, Felicita S, Lopez A, Gana M, Hung S, Petralanda I, 1992. Estudios epidemiologos sobre malaria en el Amazonas: 1990-1992. Mem CAICET 2: 13.
33. Veeken H, 1993. Malaria and gold fever. Br Med J 307: 433-434.
34. PAHO, 1986. Malaria control in the Americas: a critical analysis. Pan Am Health Organ Bull 20: 304-320.
35. PAHO, 1988. Status of malaria in the Americas. Pan Am Health Organ Bull 22: 92-103.
36. Vosti S, 1990. Malaria among goldminers in southern Para, Brazil: estimates of determinants and individual costs. Soc Sci Med 30: 1097-1105.